The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of AstraZeneca's 2013 sales performance.
AstraZeneca (AZ) and Daiichi Sankyo have announced positive results from a late-stage study of their investigational TROP2-targeting antibody drug conjugate, datopotamab deruxtecan, in certain lung cancer patients.
AstraZeneca (AZ) has shared updated results from a late-stage study of its Imfinzi (durvalumab) plus Imjudo (tremelimumab) treatment plan in certain patients with hepatocellular carcinoma (HCC), the most common type
Rebekah Martin is SVP of Reward, Inclusion &Talent Acquisition at AstraZeneca.
cases. These ranged from drug discovery management to AstraZeneca’s application of the technology with chemical reactions, to predict new reactions and molecular synthesis – with the potential to possibly circumvent or ... Beyond AstraZeneca’s
He has worked across a diverse range of therapeutic areas for clients including GSK, Pfizer, Novartis, Johnson &Johsnon, AstraZeneca, Gilead, Roche, Merck, Boehringer Ingelheim, Eli Lilly, Novo Nordisk, Takeda and Biogen.
[ Previous 5 results ] 6 7 8 9 10 11 12 13 14 15 [ Next 5 results ]
No results were found
Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...